Mice given extra GLP-1 (via gene therapy or a GLP-1 agonist drug) developed more oxidative, fatigue-resistant muscle fibers (more Type I fibers), built up greater muscle glycogen stores, and increased mitochondrial biogenesis changes that enhanced their endurance performance (1)
You may be a candidate for a GLP-1 medication if you have: A BMI of 30 or higher, or A BMI of 27 or higher with a related health condition, such as high blood pressure, high cholesterol, or type 2 diabetes Healthy Lifestyle Habits Still Matter When Taking GLP-1s GLP-1 medications can help you lose significant weight, but theyre most effective when combined with healthy habitsnot used as a substitute
It essentially frees up more NAD+ (a vital coenzyme in metabolism), which revs up the bodys ability to burn calories and fat
Research-grade PT-141 from peptide suppliers contains the same molecular structure but is synthesised for laboratory use under different regulatory oversight typically through state-licensed compounding facilities or chemical synthesis labs
A NEW Phase 3 trial has shown that a combination therapy of cagrilintide and semaglutide (CagriSema) can lead to substantial weight loss and improved glycaemic control in adults with Type 2 diabetes and overweight or obesity